Proteomics in prostate cancer research.

Area of Science:

• Biochemistry
• Oncology
• Proteomics

Background:

• Increasing incidence of early prostate cancer (PCa) in middle-aged men.
• Limitations of current prognostic factors (tumor stage, grade) for T1c PCa.
• Inadequacy of prostate-specific antigen (PSA) as a sole prognostic predictor for low-level cases.

Purpose of the Study:

• To review proteomic analysis techniques for identifying novel prognostic indicators in prostate cancer.
• To highlight the potential of proteomics in improving patient selection for curative treatment.
• To address the urgent need for adjunctive prognostic markers in early-stage PCa.

Main Methods:

• Critical review of 2-dimensional gel electrophoresis (2-DE) for proteome research.
• Description of complementary techniques: image analysis and mass spectrometry.
• Summary of non-2-DE platforms: SELDI, ICAT, and array-based technologies.

Main Results:

• 2-DE is a powerful, albeit labor-intensive, method for analyzing cellular protein phenotype.
• Proteomic exploration can reveal gene regulations not detectable at the genetic level.
• Various proteomic techniques offer potential for discovering new PCa biomarkers.

Conclusions:

• Proteomic analysis holds significant promise for identifying novel prognostic markers in early prostate cancer.
• Advanced techniques like 2-DE are crucial for understanding the protein phenotype and improving patient management.
• Further research into proteomic markers is essential for personalized treatment selection in PCa.